Minerva Neurosciences last closed at $3.43 (+3.31%) on 2026-10-06. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -0.7×. Its overall grade ranks 75 of 740 stocks in Healthcare.
About this company
Minerva Neurosciences last closed at $3.43 (+3.31%) on 2026-10-06. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall A+ · 75/740
Valuation grade A-
Related stocks
- Sage TherapeuticsCompetitor
주요 CNS 치료제 개발 경쟁사
- Karuna TherapeuticsCompetitor
정신질환 신약 개발 분야 경쟁사
- Intra-Cellular TherapiesCompetitor
조현병·정신질환 치료제 상업화 경쟁사
About Minerva Neurosciences
- What technical signals does Minerva Neurosciences (NERV) have?
- Minerva Neurosciences current technical signals: MACD bullish cross.
- Is Minerva Neurosciences a cup-and-handle pattern?
- No. Minerva Neurosciences has no valid Cup signal right now.
- What published figures are available for Minerva Neurosciences?
- Market cap: $23.99M. Trailing 12 months PER: -0.7×. Latest quarter PBR: -1.35×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Minerva Neurosciences, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy